We are live on ! Find out more
BLACR

Bellevue Life Sciences Acquisition Corp. Rights
BLACR

Delisted

BLACR was delisted on the 14th of February, 2025.

Back to rankings

31 hedge funds and large institutions have $798K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more funds holding

Funds holding: 28 → 31 (+3)

5% less capital invested

Capital invested by funds: $838K → $798K (-$39.8K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
31
Holders Change
+3
Holders Change %
+10.71%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SOA
Sea Otter Advisors
Florida
+$18.6K
2
BI
Bulldog Investors
New Jersey
+$3K
3
UBS Group
UBS Group
Switzerland
+$3

Top Sellers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
-$13.7K
2
WC
Wealthspring Capital
New York
-$932
3
FTUS
Flow Traders U.S.
New York
-$414
4
CS
Clear Street
New York
-$95
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
1
Periscope Capital
Ontario, Canada
$130K – – –
HCM
2
Highbridge Capital Management
New York
$125K – – –
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$54K – – –
ASM
4
ATW SPAC Management
New York
$46.6K – – –
JP Morgan Chase
5
JP Morgan Chase
New York
$45K – – –
BFM
6
Boothbay Fund Management
New York
$44.5K – – –
SCM
7
Saba Capital Management
New York
$35.8K – – –
RCM
8
Rivernorth Capital Management
Florida
$35K – – –
CS
9
Clear Street
New York
$28.6K -$95 -624 -0.3%
SCM
10
Shaolin Capital Management
Florida
$28.5K – – –
EAM
11
Exos Asset Management
New York
$27.2K +$30.6K +200,000 New
Walleye Capital
12
Walleye Capital
New York
$25.2K – – –
CH
13
CVI Holdings
Delaware
$23.4K – – –
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$22.5K – – –
WAM
15
Wolverine Asset Management
Illinois
$18.2K – – –
SOA
16
Sea Otter Advisors
Florida
$17.1K +$18.6K +122,000 New
CC
17
Centiva Capital
New York
$15K – – –
AA
18
AQR Arbitrage
Connecticut
$15K – – –
Walleye Trading
19
Walleye Trading
New York
$14.2K – – –
MTCM
20
Mint Tower Capital Management
Netherlands
$11K – – –
SFM
21
Spartan Fund Management
Canada
$9.88K -$13.7K -89,400 -56%
SIA
22
Schechter Investment Advisors
Michigan
$6.32K – – –
GF
23
Gabelli Funds
New York
$4.05K – – –
SIA
24
SkyView Investment Advisors
New Jersey
$4K – – –
GCIA
25
Gabelli & Co Investment Advisers
New York
$3.12K – – –
1
2

BLACR Hedge Fund Activity: Q1 2024 in Review

31 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Rights (BLACR) for Q1 2024, worth a combined $798K — down 4.8% from $838K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BLACR positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 4 trimmed.

The largest buyer was Sea Otter Advisors, opening a new position worth an estimated $18.6K. The largest seller was Spartan Fund Management, cutting an estimated $13.7K.

  • 31 institutional investors held Bellevue Life Sciences Acquisition Corp. Rights (BLACR) as of Q1 2024, up from 28 in Q4 2023.
  • Funds reported $798K of Bellevue Life Sciences Acquisition Corp. Rights stock for Q1 2024, down 4.8% quarter-over-quarter.
  • 4 funds opened new Bellevue Life Sciences Acquisition Corp. Rights positions in Q1 2024 and 0 closed out, a net change of +4 holders.
  • The largest Bellevue Life Sciences Acquisition Corp. Rights buyer in Q1 2024 was Sea Otter Advisors, an estimated $18.6K added.
  • The largest Bellevue Life Sciences Acquisition Corp. Rights seller in Q1 2024 was Spartan Fund Management, an estimated $13.7K sold.

Based on aggregated 13F filings for Q1 2024.